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ABSTRACT 
 
Evaluation of Stress Before, During, and After Transport in Naïve Yearling Horses. 
 (May 2009) 
Shannon M. Garey, B.S., Iowa State University 
Chair of Advisory Committee: Dr. Ted Friend 
 
Recently, the European Union published regulations regarding the welfare of 
horses during transport requiring that horses be transported in individual stalls separated 
by partitions.  The objective of this study was to determine if concentrations of cortisol, 
corticosterone, or dehydroepiandrosterone (DHEA) differed among horses with no prior 
transport experience when transported in individual stalls versus loose groups.  Twenty 
naïve yearlings were assigned to either individual stalls or a loose group, then 
transported for 6 hours.  Ten horses were transported per day (5 in stalls and 5 in a loose 
group) over a two day trial.  The experiment was replicated with a second trial 35 days 
later, and utilized a switchback design where the horses exchanged treatments between 
trials.  Blood samples were collected and analyzed for cortisol, corticosterone, and 
DHEA concentrations at pre-transport, 2, 4, and 6 h of transport, and at 2 and 4 h after 
unloading.  After Trial 2, the horses’ changed housing from group paddocks to stalls and 
a follow-up experiment was conducted.  The data were analyzed using a mixed model 
repeated measures ANOVA with the animal as the subject, with trial, treatment, sample 
time, and treatment-sample time interaction in the model with unstructured covariance 
iv 
(SAS 9.1).  Differences between sample times within each trial, and pre-transport 
concentrations between trials, were analyzed using paired t-tests (SPSS 12.0.1).  No 
significant differences were found in hormone concentrations for horses transported in 
individual stalls versus in loose groups.  Horses exhibited a significant elevation in 
cortisol and corticosterone during transport which returned to pre-transport 
concentrations by 2 hr after transport (P < 0.01).  Mean pre-transport cortisol 
concentrations rose significantly in Trial 3 (7.87 ng/ml) from Trials 1 (2.71 ng/ml) and 2 
(2.84 ng/ml) (P < 0.001).  Pre-transport concentrations of DHEA in Trials 1 (482 pg/ml) 
and 2 (392 pg/ml) also rose significantly in Trial 3 (1607 pg/ml) (P < 0.01).  Changes in 
cortisol and DHEA indicated that transportation was a significant stressor for horses, 
however, being transported in a loose group versus individual stalls was not different.  
Also, housing changes from paddocks to stalls resulted in significant increases in pre-
transport concentrations of stress-related compounds.  
v 
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NOMENCLATURE 
 
h Hour 
min Minute 
sec Second 
d Day 
kg Kilogram 
m Meter 
km Kilometer 
SE Standard Error 
M   Million 
CP   Crude Protein 
Zn   Zinc 
Mn   Manganese 
Cu   Copper 
Co   Cobalt 
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1 
INTRODUCTION 
 
History 
 Horses have played a vital role in the evolution of American culture.  Up until 
the mid-1900’s, horses were a necessity for farm work and travel.  They could be found 
attached to implements, working in fields and attached to buggies, transporting people 
from farms to town and from one town to another.  With the invention of the automobile 
at the start of the 20th century and the development of tractors in the 1940’s, use of 
horses for farm work and travel was phased out.  Over the subsequent half century, 
people have shifted to using horses for a variety of recreational activities including 
showing, jumping and racing.  Horses went from a vital work animal to a largely 
recreational activity in less than 100 years.  Only a small fraction of the horse population 
are still used for ranch and farm work.  The role they currently play in our society 
oscillates between livestock and pet, with many regulators finding it difficult to handle 
the grey area that they represent.  Along with the shift in function of the horse came a 
shift in perspective of how the animal should be treated.  As we have progressed from an 
age of horse-powered transportation, we now find ourselves in an ironic position of 
transporting those animals for recreational and commercial purposes. 
 
Equine Social Behavior 
Horses evolved as a social species living and moving in small groups and rarely  
_____________ 
This thesis follows the style of Journal of Animal Science. 
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living in isolation.  Inclusion within a herd is an essential defense mechanism against 
predators in a wild or feral living environment.  The development of social behavior 
encourages herd stability by minimizing conflict and establishing a social structure 
(Goodwin, 2002).  Foals spend their first 2 weeks of life bonding and engaging in play 
activity with their mother.  Beyond 2 weeks of age, play interactions with the dam 
steadily decrease while play and social interactions with other members of the herd 
steadily increase (Houpt, 1991).  The play maneuvers that foals exhibit during this stage 
of their lives mimic social dominance and mating behaviors that they will use with herd 
mates as adult horses (Houpt, 1991).   
Horses display a social dominance structure within all groups of 2 or more 
animals.  There is clearly a most dominant horse that all others are submissive to and a 
least dominant horse that is submissive to all others (Waring, 1983).  Horses that are not 
the most dominant, nor least dominant have differing dominance patterns with each 
other, where all animals have a position in relation to all other animals, although the 
structure may not necessarily be linear.  Dominance is established between two horses 
during the first few hours of interaction (Waring, 1983).  Once a dominance structure is 
set within a herd, it will remain constant until a member of the herd leaves or a new 
member joins (Goodwin, 2002). 
Horses spend up to 75% of each day grazing as a group (Davidson and Harris, 
2002).  In the event of a threat, individual animals will stop grazing and move closer to 
other members of the herd (Waring, 1983).  If the threat appears to be a predator and 
continues to advance toward the herd, the horse closest to it will pivot and begin a flight 
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response with the other members of the herd immediately following (Waring, 1983).  
When flight is not an option, horses will use aggression to fight off a threatening 
individual by biting, kicking with one or both rear legs or striking with one or both front 
legs.  These same aggressive actions are often exhibited by dominant horses toward 
submissive individuals when they are kept in a high density area where the submissive 
animal is unable to retreat. 
 
Commercial Livestock 
Horses represent a significant portion of the agricultural industry today.  Besides 
livestock sales, horses have a considerable impact on the economy.  The total number of 
horses living in the United States is between 4 M and 9 M, as estimated by the United 
States Department of Agriculture and the American Horse Council (American Horse 
Council, 2005, USDA, 2007a).  While a majority of these animals are privately owned 
and used for recreational purposes, a small portion of them are commercial livestock and 
are being sold for slaughter. 
The practice of slaughtering horses in the United States stopped in 2007 due to 
state laws in Texas and Illinois banning the practice for human consumption; the only 
states where slaughter plants were operating at the time (Illinois General Assembly, 
2007, Texas Statutes Agriculture Code, 1949).  However, prior to the closing of those 
facilities, the United States was processing between 50,000 and 350,000 horses per year 
(Fig. 1) since the U.S. Department of Agriculture began reporting equine slaughter 
statistics in 1980 (USDA, 2007b).  
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Figure 1. Number of federally inspected horses that were slaughtered in the U.S. 
between 1980 and 2007 according to the National Agriculture Statistics Service (USDA, 
2007b). 
 
In comparison to cattle slaughter facilities, relatively few equine slaughter 
facilities were open prior to 2007.  In the past five years, only 4 plants, located in Texas, 
Illinois and Nebraska were processing horses, causing many horses that were being 
transported to slaughter to spend several hours in transit.  In addition to the horses being 
commercially transported to U.S. facilities, many horses were being transported to 
Canadian and Mexican slaughter plants.  In 2007, the year that the last equine slaughter 
facility closed in the U.S., exports of U.S. horses to Mexico for slaughter jumped over 4 
times from about 11,000 horses to over 44,000 horses (Nolen, 2008). 
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Transport Legislation 
In the United States, the 1996 Farm Bill called for USDA regulation of 
commercial transport of horses.  That regulation came in 2002 in the form of 9 Code of 
Federal Regulations (CFR) Chapter 88.  Chapter 88 of the Code bans the transport of 
commercial horses on two layers, as in a double-deck trailer, which is common in the 
transport of other livestock species (U.S. CFR, 2002).  The same chapter sets out 
requirements for supplying adequate quality feed and potable water to horses within at 
least 6 hours of transport, segregating stallions and other aggressive animals during 
transport and ensuring adequate floor space for each animal.  This regulation addresses 
the physical condition of the horses as well, requiring that the animals transported are fit 
for travel, are not blind or lame, are able to walk unassisted and are not in danger of 
giving birth near the time of transport (U.S. CFR, 2002).  The final portion of the chapter 
gives the U.S. Department of Agriculture the ability to fine persons found in violation of 
the code up to $5,000 per violation, with each improperly transported horse considered a 
separate violation. 
While 9 CFR Chapter 88 set out basic requirements with financial penalties for 
violations, the Agriculture and Resource Management Council of Australia and New 
Zealand makes much more specific recommendations to address the animals’ physical 
and behavioral well-being during transport in The Australian Model Codes of Practice 
for the Welfare of Animals: Land Transport of Horses.  This 19 page document focuses 
with great detail on every aspect of the transport experience, including recommendations 
on handling to minimize stress, food, water, shelter and rest prior to transport, and even 
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the condition of loading facilities.  More notably, it recommends segregation of horses in 
stalls during transport using adjustable partitions positioned at a right angle to the 
direction of travel to reduce the likelihood of injury (ARMCANZ, 1987).  In group 
transported horses, the code suggests that weanlings up to 12 months be allowed 0.7 m2 
per horse, those 12 to 24 months of age be given 0.9 – 1.0 m2 per horse and adult horses 
over the age of 24 months be allowed 1.2 m2 per horse (ARMCANZ, 1987).  While this 
code is much more specific than the 9 CFR Chapter 88 published in the U.S., it is only a 
set of recommendations, and has no stipulated consequences for failure to comply. 
The most recent and most stringent legislation of horse transport has come from 
the European Union (EU), where, in 2005 The Council of the EU published Council 
Regulation (EC) No 1/2005 On the Protection of Animals During Transport and Related 
Operations.  Some of the specific mandates included in this document are that all non-
registered horses be transported in single layer trailers with a minimum of 75 cm of 
clearance above the withers and must be offered food and water every 8 hours during 
transport.  The maximum transport period is 24 hours and during long journeys, the 
horses are to be stalled individually unless they have a foal.  Stalls are to be made out of 
adjustable partitions, and each horse is to be given 1 m2 to 1.75 m2 of space depending 
on age.  Horses over 8 months of age are to wear halters and that when tied, they must be 
able to lie down, eat and drink (Council of the European Union, 2005).  In addition to 
the regulations for transport, the document gives authority to individual member states to 
ensure compliance and seek out those persons that fail to comply. 
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In addition to the current codes and regulations, bills have been presented in the 
U.S. to further regulate equine transport.  To date, there have been 2 bills proposed in the 
current session of Congress that would have a direct impact on the transportation of 
horses if passed and signed into law.  The first was proposed on January 8, 2009 as an 
amendment to the United States Code Title 49, Transportation, which seeks to eliminate 
the transport of any horse in a double-deck trailer (U.S. House of Representatives, 
2009a).  While the regulations set forth in 9 CFR 88 made transport of commercial 
slaughter horses in double-deck trailers illegal in 2001, this bill would apply that 
standard to the transport of all horses.  The bill has been called the Horse Transportation 
Safety Act of 2009 and has been referred to the Committee on Transportation and 
Infrastructure for review (U.S. House of Representatives, 2009a).   On January 14, 2009, 
a second bill was introduced regarding regulation of equine transport.  This bill, called 
The Prevention of Equine Cruelty Act of 2009, is a proposed amendment to Title 18 of 
the United States Code, Crimes, Chapter 3, Animals, Birds, Fish and Plants.  If passed 
into law, this bill would make transportation of slaughter horses for the purpose of 
human consumption a criminal offense (U.S. House of Representatives, 2009b).  Seven 
similar versions of this bill have been previously presented to both the House of 
Representatives and the Senate in past sessions, but have not made it through the 
legislative process and have expired at the conclusion of each session.  The first version 
was presented to the House in February 2002, and like the versions subsequently 
presented to the House in February of 2003 and to the Senate in April of 2004, it was 
referred to a committee for review and never made further progress (U.S. House of 
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Representatives, 2002, U.S. House of Representatives, 2003, U.S. Senate, 2004).  In 
February of 2005, a fourth version was presented to the House which was reviewed and 
reported on by the House Agriculture Committee.  Two amendments were proposed and 
rejected, and the bill passed the House vote 263 to 146.  From there it was sent to the 
Senate for review and vote, but failed to progress and, like the previous versions, expired 
at the end of the session (U.S. House of Representatives, 2005).  During that time, a fifth 
version was presented to the Senate in October of 2005, which was referred to a 
committee for review, also failed to progress and ultimately expired (U.S. Senate, 2005).  
A sixth version was presented in January of 2007, and did not advance past introduction.  
No action was taken and, like the others before it, the bill expired at the conclusion of 
the session (U.S. House of Representatives, 2007).  The most recent version to be 
presented prior to the current session was introduced to the House in July of 2008 and 
was reported on by the Committee on Agriculture in September of that year.  It also 
failed to progress from that point and expired (U.S. House of Representatives, 2008). 
While the previously mentioned federal legislation is pending, there are several 
states actively working toward opening new equine slaughter facilities.  In late February, 
2009, the Montana House of Representatives voted on and passed a bill creating 
authorization for the construction of an equine slaughter facility and prohibiting any 
court injunction from delaying such a project.  The bill has been sent to the State Senate 
for review and vote (Montana Legislature, 2009).  At the same time, both North and 
South Dakota have passed legislation in their respective Houses of Representatives to 
9 
study the feasibility of opening equine slaughter facilities in their states (North Dakota 
Legislative Assembly, 2009, South Dakota Legislative Assembly, 2009). 
 While the future of equine slaughter in the United States is uncertain, the demand 
for horse meat worldwide remains.  That demand, along with the movement of horses 
for rendering in the U.S. and abroad, ensures that the transport of horses as commercial 
livestock will continue, and the need for regulation will remain.   
 
Behavior During Transport 
As adults, horses within a herd will express dominance only in an effort to 
control space and avoid conflict (Goodwin, 2002).  When space is restricted, the 
avoidance structure of a herd can become unstable and conflicts may result (Goodwin, 
2002).  A mathematical model was developed in 1998 to quantify a safe density of loose 
horses during transport.  The model suggested that horses be transported at a density 
(kg/m2) equal to 54.837 times the (average animal weight)0.325 (Whiting, 1999).  The 
model was based on observations of stocking densities and injuries in foals and mature 
horses transported to slaughter in 1996 and 1997.  Whiting (1999) noted that most horses 
were transported between 200 and 350 kg/m2 with only 2 reported injuries and neither 
required veterinary treatment.  In 1999, a study done at the University of California at 
Davis reported finding fewer injuries of commercially transported horses grouped in a 
higher density of 1.14 m2 to 1.31 m2 per horse versus a moderate density of 1.40 m2 to 
1.54 m2 per horse (Stull, 1999).  However, in the same study, Stull (1999) also reported 
increased white blood cell counts, total protein concentrations and 
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neutrophil:lymphocyte concentrations in the higher density group.  Stull’s findings 
appeared to concur with a previous study on loading density in cattle transport that 
concluded that transporting cattle at higher loading densities lowered frequency of 
movement and heart rates, suggesting that animals utilize the presence of other animals 
for stability (Eldridge et al., 1988).  However, results of a 1992 study comparing cattle 
transported at high, medium, and low densities clearly indicated that cattle were more 
stressed under higher stocking densities (Tarrant et al., 1992).  The study found that 
plasma concentrations of cortisol, glucose, and creatine kinase increased as stocking 
density increased, as did carcass bruise scores (Tarrant et al., 1992).   Similarly, a 2000 
study of stocking density of horses found that animals transported at a high density of 
1.28 m2 per horse, versus a low density of 2.23 m2 per horse, were more likely to fall or 
be injured, and had a decreased the likelihood of rising to their feet after falling (Collins 
et al., 2000).  More recently, researchers analyzed videotaped activity of horses during 
six 18-20 hour periods of transport in high, medium and low densities.  Density had less 
of an effect on aggressive behavior than did individually aggressive horses that were 
being transported in each group, but that horses were more likely to fall when 
transported in high density (Iacono et al., 2007). 
A horse’s ability to balance during transport is central to its behavior while in 
transit and may contribute to the amount of stress experienced by the animal.  Muscle 
activity expressed by a horse to maintain its upright position during transport can be 
used as a direct indication of muscular and emotional stress that a horse experiences as a 
result of road conditions and driving ability (Giovagnoli et al., 2002).  Clark et al. (1993) 
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studied horses’ ability to balance during transport based on forward or rear-facing 
orientations and found that horses facing away from the direction of travel had fewer 
indications of loss of balance, however, heart rate and cortisol, used as measures of 
stress, were not different based on orientation (Clark et al., 1993).  A later study by 
Gibbs and Friend (1999) on orientation and balancing ability found that horses have a 
slight preference for a 45 degree angle orientation, but that different orientations had no 
effect on the animals’ ability to balance during transport.   
Orientation preferences have also been researched in an effort to minimize stress 
during transport, but with limited conclusions of effect on all horses.  As previously 
mentioned, Clark et al. (1993) reported finding no effects of orientation on cortisol and 
heart rate measurements, but suggested that the stress induced by transport may have 
masked differences of orientation.  Kusunose and Torikai (1996) conducted a study of 
the behavior of yearling Thoroughbreds while being transported in loose pairs.  They 
found that when drivers used minimal acceleration and deceleration, the horses spent 
more time facing away from the direction of travel, however, when drivers made 
repeated sudden stops, the horses did not show a preference for orientation (Kusunose 
and Torikai, 1996).  Also in 1996, researchers at the University of Edinburgh transported 
a group of horses in a forward-facing orientation, then reversed to rear-facing orientation 
for a second transport period.  They found that the horses had a slight tendency for 
lowered heart rates when the horses were forward-facing, but they also found a slight 
tendency for more frequent movement in the horses when they were forward-facing 
(Waran et al., 1996).  Toscano and Friend (2001) conducted a study placing rear-facing 
12 
and forward-facing animals in the same trailer and completing a course of accelerations, 
decelerations, bumps and turns.  The results suggested that, while some horses were 
better able to maintain balance in one orientation versus the other, the results were mixed 
for individual animals, and it was concluded that individual factors are more significant 
than orientation in the animal’s ability to balance during transport (Toscano and Friend, 
2001). 
Dehydration and fatigue can occur after prolonged periods of transport.  A 
previous study conducted by this research group found that horses that had been 
deprived of water for 6 hours prior to loading were able to be transported for up to 24 
hours in hot, humid conditions before becoming severely dehydrated and fatigued 
(Friend et al., 1998).  A follow-up study in 2000 concluded that transport of healthy 
horses for greater than 24 hours without water caused severe dehydration, while horses 
transported up to 30 hours with periodic access to water still exhibited increasing 
symptoms of fatigue (Friend, 2000).   A study done at the University of California at 
Davis concurred that when horses are transported up to 24 hours, they exhibit symptoms 
of dehydration, depressed feed and water intake and post-transport weight loss.  
Physiologically, this study also showed that the horses’ packed cell volume increased, 
along with cortisol concentrations during the transport period (Smith et al., 1996).  
Researchers followed-up this study in 2000 by evaluating indices of stress in horses 
transported for extended periods during hot summer conditions.  They reported that after 
24 hours of transport, the horses lost weight, exhibited symptoms of dehydration, had 
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increased concentrations of lactate, glucose and cortisol, and showed an increased 
neutrophil:leukocyte ratio (Stull and Rodiek, 2000). 
In an attempt to alleviate the stress of transport on horses, researchers at the 
University of Bristol studied the effects of blindfolding the animals during handling and 
loading into transport vehicles.  They evaluated the horses’ heart rates and behavior and 
concluded that blindfolding increased the animals’ stress levels and made them more 
difficult to handle (Parker et al., 2004). 
 
Indices of Stress 
 As one can see from the numerous studies conducted on transport stress in 
horses, there are many ways to identify stress in animals.  Behavioral indicators of stress 
that have been measured during transport include number of movements, number of 
falls, number of aggressive acts toward other horses, position of the animal’s head and 
amount of eating and drinking.  In addition, researchers have used a variety of 
physiological measures such as electromyography of muscle activity, heart rate, 
respiratory rate, body temperature, weight, white blood cell count, red blood cell count, 
packed cell volume, neutrophil:lymphocyte ratio, and concentrations of ACTH, cortisol, 
glucose, lactate, plasma protein and creatine kinase.  While many of these measures give 
an indication of stress in an animal, no one measure has been shown to definitively 
quantify stress. 
General Adaptation Syndrome. In the mid-1940’s, Hans Selye described what he 
called the General Adaptation Syndrome, which encompassed three stages of a stress 
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response in animals and humans.  He theorized that in the first stage, called alarm, when 
a stressor is presented, the pituitary is stimulated to express adrenocorticotropic hormone 
(ACTH) which causes the adrenal cortex to produce glucocorticoids and 
mineralocorticoids, which travel throughout the body to target organs (Selye, 1951).  In 
this stage the sympathetic nervous system is engaged through increased heart rate, blood 
pressure and respiratory rate, supplying the body with increased blood flow and oxygen.  
Cortisol, a glucocorticoid, stimulates liver cells to perform gluconeogenesis and 
subsequently, blood glucose concentrations rise supplying the body with higher energy 
levels.  In the second stage, adaptation, the initial hormone response subsides, while the 
body continues to resist the stressor and the immune system becomes suppressed.  
Finally, in the exhaustion stage, the body has depleted its resources and stops resisting.  
In extreme cases, the exhaustion stage results in death. 
 Suppressed Immune Function. Respiratory disease has been one of the biggest 
concerns of transporting livestock for many years.  Many animals that appear to be in 
good health when loaded for shipment begin to express symptoms of respiratory disease 
within hours of being unloaded after transport.   
Researchers at Kitasato University in Japan reported in 1995 that after studying 
young Thoroughbreds that were transported for approximately 41 hours, transport 
predisposes the upper respiratory tract and lower airways of horses to insult from 
pathogens, which can lead to respiratory disease and potentially, pneumonia (Oikawa et 
al., 1995).  Results of a subsequent study by the same research group suggest that 
transporters who increased rest periods and cleaned out the trailer during those periods 
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could reduce overall transport stress on the horses as well as reduce airborne respiratory 
irritants (Oikawa et al., 2005). 
Cortisol. When studying stress, glucocorticoid concentrations in the blood can 
give researchers an indication of an individual’s reaction to a given stressor.  As early as 
1960, researchers were correlating corticosteroids with stress response.  Parkinson et al. 
(1960) determined that there were differences in corticosteroid concentrations between 
European and Bantu patients which they theorized contributed to differing stress 
reactions after surgical procedures.  By the mid-1970’s researchers at Bucknell 
University had demonstrated differences in cortisol concentrations between dominant 
and submissive squirrel monkeys when exposed to a series of stressors (Manogue et al., 
1975).  Later research directly linked psychological stress to increased cortisol 
concentrations when a study comparing military parachutists before and after their first 
two jumps from an airplane, found significant increases in cortisol, prolactin and 
thyrotropin (Schedlowski et al., 1992).  Cortisol does not, however, correlate linearly to 
stress experienced over long periods of time.  A 6 d study of military cadets on a 
deprivation diet with only 1 – 3 h of sleep per day that were subjected to intense physical 
training activities found that cortisol peaked on d 3 and was returned to near basal levels 
by d 5, although the cadets remained under intensely stressful conditions until d 6 
(Opstad, 1992).  However, cortisol is commonly used to identify stress, especially short-
term stress, in human and animal research studies. 
 DHEA. A hormone that has recently been used in the field of stress research is 
dehydroepiandrosterone (DHEA).  DHEA is a neurosteroid produced by the adrenal 
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glands.  Researchers at the Technical University in Munich, Germany have recently 
determined that severely depressed patients exhibited increased diurnal DHEA 
concentrations over healthy control patients when evaluated every 30 min for 24 hours 
(Heuser et al., 1998).   
As with cortisol, DHEA secretion is initiated by ACTH, although differences 
between DHEA and cortisol expression have been observed and are not fully 
understood, and some researchers are using DHEA:cortisol ratio as a physiological 
measure in their studies (Scott et al., 2000, Yehuda et al., 2006).  Scott et al. (2000) 
demonstrated a difference in DHEA:cortisol ratio over time between chronic fatigue 
syndrome patients and healthy control patients.  The researchers administered ACTH to 
both groups and evaluated the subsequent plasma DHEA and cortisol concentrations.  
While the control patients exhibited a decrease in the ratio, the patients with chronic 
fatigue syndrome did not (Scott et al., 2000).    
A post-traumatic stress disorder (PTSD) study conducted at the Mount Sinai 
School of Medicine found that veteran patients with the disorder had significantly higher 
DHEA concentrations than veteran patients without PTSD (Yehuda et al., 2006).  
Additionally, researchers working on that study were able to show a correlation between 
DHEA concentrations and severity of the disorder symptoms.  They were also able to 
demonstrate a correlation between cortisol:DHEA ratio and the severity of childhood 
trauma, as well as PTSD symptom severity (Yehuda et al., 2006). 
 While there is still a lot of information about DHEA that is unknown, these early 
studies indicate that there may be a link between long-term stress disorders and elevated 
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concentrations of DHEA or increased DHEA:cortisol ratios.  If DHEA can be shown to 
be an indicator of long-term stress, researchers may be able to identify and change 
stressors in animal production that lead to impaired growth or performance. 
  
Objectives 
 The objectives of this study were to determine if differences in physiological 
stress markers exist when horses are transported in individual stalls versus being 
transported as a group.  Further, the study sought to determine if horses continue to 
exhibit elevated stress markers after the termination of a 6 h transport period.  Stull and 
Rodiek (2002) concluded that when horses were transported for long periods of time, 
those that were cross-tied exhibited greater indications of stress and took longer to return 
to pre-transport measurements. 
Additionally, this study sought to determine if changes in housing and exercise 
patterns have an effect on the response of horses during transport. 
 
Hypothesis 
 It may be hypothesized that, due to the social behavior of horses, animals may 
exhibit decreased physiological indicators of stress when transported in a group, as 
opposed to enduring the stress of transport in an isolated stall.  This researcher 
hypothesizes that termination of transport, the stressor, will result in a quick reduction of 
glucocorticoids to pre-transport concentrations as the animals cease the resistance stage 
of adaptation. 
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MATERIALS AND METHODS 
 
Horses 
Twenty yearling quarter horses that had no prior hauling experience were 
selected from the herd at the Texas A&M University Horse Center.  All of the yearlings 
selected were simultaneously participating in a nutrition and exercise physiology study 
examining the influence of dietary supplements on the incidence of gastric ulcers.  All 
horses were receiving 1.25% of body weight of CP textured grain mixture, 1% of body 
weight of hay as their basal diet and one of three supplement treatments.  Seven horses 
were receiving a sulfated form of trace mineral containing Zn, Mn, Cu, Co and Calcium 
carbonate added to the grain mixture at 41.6 mg/kg of body weight.  Six horses were 
receiving a proteinated form of trace mineral containing Zn, Mn, Cu, Co and Calcium 
carbonate added at 41.6 mg/kg of body weight.  The remaining seven horses were given 
no supplement to their daily grain and hay diet.  Horses were fed twice a day for 3 h per 
feeding period.  During feeding periods, horses were placed in assigned feeding stalls 
within the nutrition barn at the Horse Center, and stall assignments remained consistent 
throughout Trials 1 and 2.  Between feeding periods, the horses were housed in group 
paddocks around the perimeter of the nutrition barn.  Group paddocks were assigned by 
feed treatments, such that all horses within a feed treatment shared a paddock. While at 
the Horse Center, horses were exercised 3 d per week for 20 min per d, by being 
enclosed in an automated equine walker. 
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All horses were assigned a temperament score of 1-5 based on the primary 
caretaker’s experiences and interactions with each animal over the past year.  The horses 
were then blocked by temperament score and diet, and assigned to one of two treatment 
groups for transport; tied in individual stalls or loose group. 
 
Transport and Treatments 
Three trials were conducted in which each horse was transported for 6 h.  Each 
trial was completed over a 2 day period and there were 35 days between trials.  Five 
horses from each treatment group were transported on the first day and the remaining 
five horses in each treatment group were transported on the second day.  Using a 
switchback design, the treatment that each horse was exposed to in the first trial was 
reversed for the second trial.  Trial 3 was conducted as a follow-up in which each horse 
was exposed to the same treatment they received in Trial 1.   
The study was carried out using a custom built 16.2-m long x 2.4-m wide x 2.62-
m high, single-deck, slat sided trailer (Barrett Trailers, Purcell, Oklahoma) pulled by a 
tractor.  The trailer was divided into three sections: individual stalls, a loose group 
compartment and a small staging area for sample collection in the center (Fig. 2).  At the 
conclusion of each trial day, the placement of the stalls and group compartment was 
reversed within the trailer to mitigate any confounding effects of traveling in the front 
versus the rear portion of the trailer.  In addition, the direction of the stalls was reversed 
to mitigate any confounding effects of position or air flow when facing the passenger 
side versus the driver side of the trailer (Fig. 3). 
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Figure 2. Photograph of the tractor and trailer in which the horses were transported.  The 
vertical support posts that were spaced at 0.914 m intervals and were used to attach stall 
partition panels and group compartment gates are visible from the outside.  Traction bars 
on the floor of the ramp can also be seen. 
  
 
 
 
 Stalls Group Compartment 
 
 Group Compartment Stalls 
Figure 3. Floor diagram of the trailer showing stall and loose group placement during 
the first (top) and second day (bottom) in Trials 1 and 3.  Configuration was reversed in 
Trial 2, such that loose horses were in the front of the trailer on the first day (bottom) 
and in the rear on the second day (top). 
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All horses were haltered during transport, and the stalled horses were tethered 
with a 0.46 m trailer tie made of bungee.  The trailer ties were connected by a bull snap 
to the frame of the trailer approximately 0.2 to 0.3 m above the horses’ topline, and 
connected, below the jaw, to the O-ring of the horses’ halters by a quick-release clip. 
 
Loading and Unloading.  The horses were loaded and unloaded using a portable 
livestock loading ramp with semi-solid sides and evenly spaced floor bars for traction.  
Gates were placed from the door of the barn to the ramp in a funnel design to encourage 
forward movement in the direction of the trailer (Fig. 3).  Because the horses used in this 
study had no previous transport experience, all horses were conditioned to loading and 
unloading 3 d prior to the start of Trial 1.  During this conditioning phase, each horse 
was gently encouraged to enter the ramp and the trailer without force.  Once inside, all 
horses were placed in an individual stall and tethered to a trailer tie for less than 1 min, 
while the stall was closed.  The horses were then lead back to the ramp and allowed to 
unload at their own pace. 
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Stalls.  Five individual stalls were constructed by diagonal placement of six 
3.048 m utility panels (Priefert, Mount Pleasant, TX) at 0.914 m intervals, with each 
panel attached to a support post of the trailer by a, 3/16 inch chain and galvanized smooth 
wire (Fig. 4).  The panels were elevated such that the lower bar was 0.914 m off the floor 
of the trailer to prevent the horses from getting hooves or legs entangled in any open 
portion of the partitions.  Once horses were loaded into each stall, the partition was 
closed and a set of 3/16 inch chains were used to attach the panel to the opposite wall of 
the trailer.  Each stall encompassed 2.79 m2, although the horses were not able to utilize 
the entire space because of the diagonal presentation of the stalls and because they were 
tethered.  Because the horses were tied, the portion of the stalls to which the horses had 
access was 0.711 m by 2.032 m, which gave each horse 1.44 m2 of floor space.  This 
resulted in an average of 263 kg/m2 per horse for the first trial, 279 kg/m2 per horse for 
the second trial, and 287 kg/m2 per horse for the third trial, given the inter-trial growth of 
individual horses. 
 
23 
 
Figure 4. Photograph of diagonal stall design and placement within the trailer, showing 
elevated partitions and how each horse was loaded and unloaded. 
 
Group Compartment.  The group compartment was constructed using the two 
2.54 m solid swing gates that were manufactured specifically for the trailer.  One gate 
remained in the factory installed mounting, while the second gate was positioned at the 
support post that best yielded the desired amount of floor space.  This design allowed the 
gate on the factory installed mounting to swing freely and latch securely.  The second 
gate was firmly attached using four 3/16 inch galvanized chains at both top corners and 
around the central part of the gate on each side.  The lower part of the gate was secured 
using galvanized smooth wire applied in approximately 8 layers.  In Trial 1, the movable 
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gate was placed 2.29 m away from the factory installed mounting and for Trials 2 and 3, 
it was placed 2.74 m from the first gate to allow for inter-trial growth of the horses.  
There was a total of 5.82 m2 of floor space in Trial 1, and 6.96 m2 of floor space in Trials 
2 and 3.  In Trial 1, the loose horses averaged 325 kg/m2 of floor space, while in Trials 2 
and 3, the horses averaged 284 kg/m2 and 299 kg/m2 of floor space respectively. 
 
Sample Collection 
A pre-transport sample was drawn 15 min prior to loading.  Additional samples 
were drawn after 2, 4 and 6 h of transport while the horses were still inside the trailer, 
and two final samples were collected at 2 and 4 h after unloading.  To avoid scar tissue 
buildup from multiple collections at the same site, horses were marked at 6 different 
sites along the jugular vein prior to the start of each trial.  Blood samples were collected 
using 20 gauge 1½ inch needle with holder (Vacutainer® Becton, Dickinson and 
Company, Franklin Lakes, NJ) and 9ml plastic evacuated collection tubes containing 
sodium heparin (Vacuette, Greiner Bio-One, New York, NY).  Immediately after each 
sample was collected, the tubes were inverted multiple times and placed on ice until the 
total collection was complete.  Sampling time ranged from 20-30 minutes per collection 
for all ten horses. 
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For collection of the pre-transport sample and those drawn after unloading, each 
horse was haltered in its feeding stall and one researcher used a fluttering motion over 
the horse’s left eye for distraction while the second researcher applied pressure to the left 
jugular vein for 5-25 sec, inserted the needle and attached the evacuated tube.  The order 
of collection followed the order in which the horses were stalled.  However, when the 
horses were loaded in the trailer, the stalled horses were collected in the reverse order 
that they were loaded, and the group horses were collected in the order that they were 
caught when the researchers entered the compartment.  Due to the secure attachment of 
the stall partitions, stalls were not opened to access the horses for blood sampling during 
transport.  Instead, the researchers entered each stall by ducking under each panel and 
untying the horse from the trailer and backing it into the unoccupied portion of the stall.  
After the sample was collected, a researcher would remain with each horse to keep them 
restrained while samples were collected from the remaining horses (Fig. 5).  Once all 
samples were drawn, the researchers returned to each stall, reattached the horses to the 
trailer using the trailer tie and then exited to the central staging area of the trailer. 
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Figure 5. Photograph of the in-stall sample collection showing horses being restrained 
by one researcher while another ducks under a partition to get to the next horse.  Also 
shown is the height at which each horse’s head was tied and the chains and wire that 
held each partition to a support post of the trailer. 
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Once all horses had been sampled, the tubes were again inverted multiple times 
to ensure thorough mixing.  In Trials 1 and 2, the tubes were then processed through a 
leukocyte capturing filtration system (LeukoLOCKTM Total RNA Isolation System, 
Ambion, Inc., Austin, TX) that collected the filtered blood in a glass evacuated 
collection tube with no chemical additives (Vacutainer, Becton, Dickinson and 
Company, Franklin Lakes, NJ).  The filters were further processed by adding an RNA 
preservative (RNAlater, Ambion Inc., Austin, TX) and stored at -20ºC.  The filtered 
blood was then centrifuged at 3300±165 rpm for 10 min and the plasma supernatant was 
collected into 5 ml snap-cap tubes and stored at -20ºC.  During Trial 3, the blood 
samples were not filtered for leukocytes, but were immediately centrifuged for plasma 
collection as previously described. 
 
Housing Change 
Five days after the conclusion of Trial 2, all 20 horses were moved from the 
Texas A&M University Horse Center to the Texas A&M University Freeman Arena.  
The horses switched from group paddock housing at the Horse Center to being stalled 
individually in solid-wall stalls at Freeman Arena. They were exercised for at least 15 
min per day, 3 days a week.  For the first half of the period that the horses were housed 
at Freeman Arena, 10 of them were involved in an undergraduate class where they were 
lounged for 15 min per day, as well as being handled and groomed for an additional 45 
min per day, 5 days per week.  The remaining 10 horses were lounged for 15 min per 
day, 3 days per week and were turned out in groups of 2 for 45 min per day, 2 days per 
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week.  For the second half of the period that the horses were housed at Freeman Arena, 
the exercise treatments were reversed.  
 
Hormone Assays 
Plasma samples that were stored at -20°C were analyzed by colorimetric ELISA 
for cortisol, corticosterone and dehydroepiandrosterone concentrations.  Complete 
ELISA kits were used for all assays (Assay Designs, Ann Arbor, MI).  A steroid 
displacement reagent was added to cortisol and corticosterone samples before testing to 
facilitate measurement of total hormone concentrations as opposed to free hormone 
concentrations.  Protocols for each kit were followed exactly as written.  Samples were 
run in duplicate and plates were read at 405 nm optical density on a plate reader (Wallac 
Victor II 1420, Perkin Elmer, Waltham, MA).  Known concentration standards were 
used on every plate to optimize comparisons between plates.  Data obtained from the 
plate reader were inputted into a curve-fitting software program (StatLIA®, Brendan 
Technologies, Inc., Carlsbad, CA) that calculated total concentrations of each hormone 
based on averages of the duplicate samples in comparison to the generated logarithmic 
curve of the known standards. 
 
RNA Extraction 
Leukocytes that were captured by filtration were rinsed with Phosphate Buffered 
Solution to remove the RNA preservative that was added during sample collection.  The 
filters were then flushed with a cell lysing reagent and the genetic material infused 
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product was collected into a 15 ml centrifuge tube.  Further extraction of the RNA from 
the liquid followed the protocol included with the complete filtration and extraction kit 
(LeukoLOCKTM Total RNA Isolation System, Ambion, Austin, TX).  Within the 
protocol, RNA was bound to beads and washed repeatedly with isopropanol.  A DNase 
reagent was applied to the samples to degrade any DNA that may have been present and 
contaminating the product.  The final RNA product for each sample was eluted from the 
beads back into solution using 50 µl of an elution solution and stored at -80ºC. 
 
RNA Analysis 
A preliminary analysis of four samples was done on a 384-well Real-Time 
Polymerase Chain Reaction (PCR) plate coated with primers for 84 human genes that are 
involved in the inflammatory response (SuperArray, SABiosciences, Frederick, MD).  
Some of the primers used on the plate included chemokines, interleukins and members 
of the tumor necrosis factor family (Appendix Table 12).  Samples were analyzed that 
were taken pre-transport and after 4 h of transport to compare effects of transport.  
Additionally, samples chosen for analysis were selected for their differences in cortisol 
concentrations.  One horse was selected that exhibited relatively low cortisol responses 
and another horse was selected that exhibited relatively high cortisol responses when 
comparing all horses at every sample time.  The pre-transport and after 4 h of transport 
samples from each horse were thawed on ice for 30 min.  The RNA was converted to 
cDNA and added to the manufacturer’s master mix by following the protocol included 
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with the plate.  The cDNA that was added to the plate was then amplified in a fast real-
time PCR system (ABI 7900HT, Applied Biosystems Inc., Foster City, CA). 
 
Statistical Analysis 
Hormone Concentrations. Treatment effects on the plasma concentrations of 
cortisol, corticosterone and dehydroepiandrosterone (DHEA) during Trials 1 and 2 were 
analyzed using a mixed model repeated measures analysis of variance with each 
individual as the subject, with trial, treatment, sample time, and treatment-sample time 
interaction in the model with an unstructured covariance (SAS 9.1, SAS Institute, Inc., 
Cary, NC).  Differences between sample time periods were analyzed using paired T-tests 
within each trial (SPSS 12.0.1, SPSS Inc., Chicago, IL).  Least squares means are 
presented where the data have been adjusted for covariance. 
Treatment effects in Trial 3 were analyzed separately from the first two trials 
because of the change in housing and exercise programs.  Hormone concentrations were 
analyzed using a mixed model repeated measures analysis of variance with each 
individual as the subject, with treatment, sample time, and treatment-sample time 
interaction in the model with an unstructured covariance. 
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Paired samples T-tests were used to compare pre-transport plasma concentrations 
of each hormone between the three trials (SPSS 12.0.1, SPSS Inc., Chicago, IL).  The 
pre-transport pooled means were compared without regard to treatment because there 
was no treatment applied prior to transport.   
A mixed model repeated measures analysis of variance with each individual as 
the subject, with trial, treatment, supplement, sample time, and treatment-sample time 
interaction in the model with an unstructured covariance was used to determine if there 
were any differences in hormone concentrations based on dietary supplement in Trials 1 
and 2.  The same procedure was used to analyze the concentrations of each hormone 
observed in Trial 3, with trial omitted from the model. 
 
RNA Analysis. Gene expression data from the real-time PCR plate were 
considered qualitative due to the lack of representation of treatments and replicates.  In 
further studies, the data collected from Real-Time PCR analyses will be quantified and 
statistically analyzed. 
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RESULTS 
Trials 1 and 2 
Cortisol.  Transport in individual stalls or in a loose group did not have a 
significant effect on cortisol concentrations in Trials 1 and 2 (Table 1).  There was no 
significant interaction between treatment and sample time (P = 0.371) and there were no 
statistically significant differences in cortisol concentrations between treatments (P = 
0.713).  Pre-transport concentrations were significantly lower than concentrations after 2 
h, 4 h and 6 h of transport, but did not differ significantly from concentrations at 2 h and 
4 h post-transport (P < 0.01). 
 
Table 1. Least squares means of cortisol concentrations (ng/ml) in relation to time 
relative to start of transport for both treatment groups during Trials 1 and 2. 
 Treatment  
Time Stall Group SEM 
Pre-transport 2.74a 2.81a 0.88 
Transport    
    2 h 19.31b 16.98b 3.24 
    4 h 20.25c 18.82b 3.80 
    6 h 16.55b 15.01c 3.14 
Post-transport    
    2 h 4.31a 4.27a 1.56 
    4 h 3.87a 2.45a 0.82 
a,b,c Means within a column without a common superscript differ (P < 0.01) 
 
Corticosterone.  Transport in individual stalls or in a loose group did not have an 
effect on corticosterone concentrations in Trials 1 and 2 (Table 2).  There was no 
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significant interaction between treatment and sample time (P = 0.470) and there were no 
statistically significant differences in corticosterone concentrations between treatments 
(P = 0.370).  Pre-transport concentrations were significantly lower than concentrations 
after 2 h, 4 h and 6 h of transport, but did not differ significantly from concentrations at 
2 h and 4 h post-transport (P < 0.01). 
 
Table 2. Least squares means of corticosterone concentrations (ng/ml) in relation to time 
relative to start of transport for both treatment groups during Trials 1 and 2. 
 Treatment  
Time Stall Group SEM 
Pre-transport 5.29a 3.35a 1.17 
Transport    
    2 h 17.91b 13.74b 2.92 
    4 h 14.11b 13.19b 2.58 
    6 h 13.17b 10.37b 2.10 
Post-transport    
    2 h 4.53a 3.23a 0.87 
    4 h 3.29a 2.56a 0.72 
a,b Means within a column without a common superscript differ (P < 0.01) 
 
Dehydroepiandrosterone.  Transport in individual stalls or in a loose group did 
not have an effect on dehydroepiandrosterone (DHEA) concentrations in Trials 1 and 2 
(Table 3).  There was no significant interaction between treatment and sample time (P = 
0. 539) and there were no statistically significant differences in DHEA concentrations 
between treatments (P = 0. 416).  Sample-time comparisons also yielded no significant 
differences. 
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Table 3. Least squares means of DHEA concentrations (pg/ml) in relation to time 
relative to start of transport for both treatment groups during Trials 1 and 2. 
 Treatment  
Time Stall Group SEM 
Pre-transport 499.8 374.4 88.2 
Transport    
    2 h 672.9 516.6 139.9 
    4 h 657.9 565.1 143.2 
    6 h 578.6 753.3 166.2 
Post-transport    
    2 h 471.3 360.0 90.7 
    4 h 589.7 339.1 114.8 
 
Hormone Concentrations During Transport.  The plasma concentrations of 
cortisol, corticosterone and DHEA from Trials 1 and 2 were subsequently analyzed at 
the three sample times during transport only.  Again, there were no statistically 
significant differences found between horses transported in individual stalls versus those 
transported in a loose group when comparing cortisol (P = 0.712), corticosterone (P = 
0.451) or DHEA (P = 0.880).  There were also no significant interactions between 
treatments and sample time. 
 
Trial 3 
Transport in individual stalls or in a loose group did not have an effect on plasma 
concentrations of cortisol, corticosterone and DHEA during Trial 3, the follow-up 
experiment (Tables 4, 5 and 6).  There were no significant interactions between 
treatment and sample time for cortisol (P = 0.308), corticosterone (P = 0.299), or DHEA 
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(P = 0.130).  There were also no significant differences between treatment groups in 
cortisol (P = 0.269), corticosterone (P = 0.681) or DHEA (P = 0.141) concentrations.   
 
 
Table 4. Least squares means concentrations of cortisol (ng/ml) (± SEM) in relation to 
time relative to start of transport for both treatment groups during Trial 3. 
 Treatment 
Time Stall Group 
Pre-transport 9.13a ± 1.68 6.55a  ± 1.67 
Transport   
    2 h 24.73b  ± 2.64 23.53b  ± 2.63 
    4 h 27.75b  ± 2.95 24.09b  ± 2.94 
    6 h 24.33b  ± 3.24 17.71c  ± 3.23 
Post-transport   
    2 h 7.24a  ± 1.42 6.71a  ± 1.40 
    4 h 7.17a  ± 1.12 6.07a  ± 1.10 
a,b Means within a column without a common superscript differ (P < 0.01) 
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Table 5. Least squares means concentrations of corticosterone (ng/ml) (± SEM) in 
relation to time relative to start of transport for both treatment groups during Trial 3. 
 Treatment 
Time Stall Group 
Pre-transport 9.99ac ± 3.34 5.33a ± 3.33 
Transport   
    2 h 15.14b ± 2.84 11.71b ± 2.83 
    4 h 16.04b ± 4.26 13.06b ± 4.25 
    6 h 15.50ab ± 4.09 11.04ab ± 4.07 
Post-transport   
    2 h 9.68abc ± 2.56 6.05a ± 2.54 
    4 h 7.25c ± 3.54 11.24ab ± 3.53 
a,b,c Means within a column without a common superscript differ (P < 0.05) 
 
Table 6. Least squares means concentrations of DHEA (pg/ml) (± SEM) in relation to 
time relative to start of transport for both treatment groups during Trial 3. 
 Treatment 
Time Stall Group 
Pre-transport 2172a ± 379 1006 ± 379 
Transport   
    2 h 725b ± 178 719 ± 177 
    4 h 953b ± 282 684 ± 281 
    6 h 1141b ± 162 798 ± 160 
Post-transport   
    2 h 997b ± 265 1074 ± 264 
    4 h 888b ± 231 912 ± 230 
a,b Means within a column without a common superscript differ (P < 0.025) 
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Pre-transport Hormone Concentrations 
 Comparisons of pre-transport concentrations of cortisol, corticosterone and 
DHEA between Trials 1, 2 and 3 were analyzed to determine effects of change from 
group paddock housing to individual stall housing (Table 7).   Plasma concentrations of 
each hormone prior to transport were not different between Trials 1 and 2 for cortisol, 
corticosterone or DHEA (P = 0.835, P = 0.424 and P = 0.401).  However, pre-transport 
concentrations of cortisol between Trials 1 and 3, and between Trials 2 and 3 were 
significantly different (P < 0.001).  Similarly, DHEA concentrations in pre-transport 
samples were significantly different between Trials 1 and 3, as well as between Trials 2 
and 3 (P = 0.001).  There were no significant differences between pre-transport 
concentrations of corticosterone prior to transport in any of the trials. 
 
Table 7. Mean pre-transport concentrations (± SEM) of each hormone in relation to trial. 
 Trial 1 Trial 2 Trial 3 
Cortisol (ng/ml) 2.71 a ± 0.91 2.84 a ± 0.84 7.87 b ± 1.11 
Corticosterone (ng/ml) 3.76  ± 1.19 4.87  ± 1.14 7.50 ± 2.27 
DHEA (pg/ml) 482 a ± 101 392 a ± 73 1607 b ± 286 
a,bMeans within a row without a common superscript differ (P < 0.01) 
 
Hormone Comparisons by Diet 
 Trials 1 and 2.  Cortisol, corticosterone and DHEA plasma concentrations from 
Trials 1 and 2 were analyzed to determine effects of dietary supplement (Table 8).  
There were no significant differences in cortisol (P = 0.943), corticosterone (P = 0.720) 
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or DHEA (P = 0.167) concentrations between horses that were fed no supplement, those 
that were fed a proteinated form of supplement and those that were fed a sulfated form 
of supplement. 
 
Table 8. Least squares means of cortisol, corticosterone and DHEA concentrations (± 
SEM) by dietary supplement treatment during Trials 1 and 2. 
 Control Proteinated Sulfated 
Cortisol (ng/ml) 10.55  ± 2.11 10.52  ± 2.86 11.09  ± 1.83 
Corticosterone (ng/ml) 8.74  ± 1.45 10.01  ± 1.89 8.45 ± 1.29 
DHEA (pg/ml) 390 ± 124 533 ± 184 640 ± 100 
 
During Transport.  Plasma hormone concentrations were reanalyzed for Trials 1 
and 2 to include only the transport period (Table 9).  The plasma concentrations of 
corticosterone and DHEA still did not differ significantly between horses fed no dietary 
supplement, horses fed a proteinated form of supplement and horses fed a sulfated form 
of supplement.  However, the plasma cortisol concentrations of the horses fed a sulfated 
form of supplement were significantly higher than the cortisol concentrations of the 
horses fed no dietary supplement and those that were fed a proteinated form of 
supplement (P = 0.04).  
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Table 9. Least squares means of cortisol, corticosterone and DHEA concentrations (± 
SEM) by dietary supplement treatment during the 6 hour transport period of Trials 1 and 
2. 
 Control Proteinated Sulfated 
Cortisol (ng/ml) 16.24a  ± 4.45 9.81a  ± 6.65 25.52b  ± 3.58 
Corticosterone (ng/ml) 6.47  ± 3.71 19.29  ± 5.60 15.92 ± 2.95 
DHEA (pg/ml) 338 ± 229 836 ± 352 631 ± 179 
a,bMeans within a row that lack a common superscript differ (P < 0.01) 
 
 Trial 3.  Cortisol, corticosterone and DHEA plasma concentrations from Trial 3 
were analyzed to determine effects of dietary supplement (Table 10).  Differences in 
cortisol and corticosterone concentrations between the groups of horses fed no dietary 
supplement, a proteinated form of supplement or a sulfated form of supplement were not 
statistically significant (P = 0.633 and P = 0.215).  However, DHEA concentrations for 
horses that were fed a sulfated form of supplement in Trial 3 were significantly higher 
than DHEA concentrations of horses fed a proteinated form of the supplement (P = 
0.002). 
 
Table 10. Least squares means of cortisol, corticosterone and DHEA concentrations (± 
SEM) for dietary supplement treatment groups in Trial 3, the follow-up experiment. 
 Control Proteinated Sulfated 
Cortisol (ng/ml) 16.43  ± 1.65 14.88  ± 1.74 14.95  ± 1.65 
Corticosterone (ng/ml) 9.62  ± 2.57 14.17 ± 2.72 9.22 ± 2.57 
DHEA (pg/ml) 857ab ± 170 649a ± 181 1511b ± 170 
a,bMeans within a row that lack a common superscript differ (P < 0.001) 
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RNA Analysis 
 Analysis of the four RNA samples on the plate coated with primers for human 
inflammatory response genes yielded quality amplification of 13 out of 84 of the target 
genes (Appendix Table 12).  From the 13 target genes that amplified, 12 of them showed 
differing expression among the 4 samples (Fig. 6) as measured by the calculation of the 
cycle at which the amplification curve crossed the threshold.  The 1 remaining gene 
showed strong amplification, but did not differ in the threshold cycle (Ct) value between 
samples.  Five additional primer sets were included on the plate to be used as 
housekeeping genes.  The primers selected for housekeeping genes typically show 
minimal differences in Ct values for all samples indicating little or no variation based on 
inflammatory response for the target species, thus making them useful for data 
correction. Of the 5 of the housekeeping genes included on the plate used, the samples 
amplified on only one primer set (Appendix Table 12).  Results from the genomic 
contamination wells, reverse transcription control wells and positive PCR controls 
indicated that the samples performed well with no contamination. 
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Figure 6. Plot of amplification of four samples chosen for preliminary analysis of 
inflammatory gene expression using human primers.  Differing colors represent 
individual genes and each line represents an individual sample.  Space between like 
colored lines indicated differences in gene expression.  All genes that failed to amplify 
are absent for clarity.  The red line indicates threshold. 
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DISCUSSION 
 
 Results from this study indicate that transporting horses in individual stalls or in 
loose groups does not reduce the level of stress experienced by naïve horses during 
transport.  These findings are inconsistent with a 2002 study conducted at the University 
of California at Davis, which concluded that horses transported for 24 hours in loose 
groups had decreased physiological measures of stress when compared to horses that 
were individually stalled (Stull and Rodiek, 2002).  That study consisted of 10 mature 
horses being transported for 24 hours in a switchback design where all horses received 
both treatments.  All horses had prior transport experience, and any potential 
confounding effects of that prior experience were not discussed in the article.  The 
researchers collected blood samples at 0, 3, 12 and 24 hours of transport and evaluated a 
multitude of physiological parameters including packed cell volume, serum total protein, 
lactate and creatine kinase concentrations, cortisol and glucose concentrations, white 
blood cell counts, neutrophil:lymphocyte ratios, aminotransferase and alpha one 
acidglycoprotein concentrations.  While the results concur with our observations of 
increased cortisol concentrations during transport for all horses, it is unclear if the 
researchers found significant differences between cortisol concentrations of horses in 
different treatment groups during transport.  From the information presented, it would 
appear that our observations of similar cortisol concentrations for both treatment groups 
after 2 h and 4 h of transport are consistent with the findings of Stull and Rodiek (2002) 
up to 3 h of transport.  However, Stull and Rodiek reported a divergence of cortisol 
43 
concentrations after 3 h of transport, with cross-tied horses expressing higher 
concentrations and loose horses expressing lower concentrations.  Over the 24 h 
transport period that Stull and Rodiek studied, they reported significant differences 
between treatment groups in white blood cell counts, glucose and cortisol concentrations 
and neutrophil:lymphocyte ratios at a significance level of P < 0.05 (Stull and Rodiek, 
2002).  It was unclear from the information presented what the significance of each 
parameter was, and at which sample times the differences were significant.  It was also 
unclear if any treatment by sample time interactions were found.  While the researchers 
reported differences in cortisol concentrations between treatment groups over a 24 h 
period of transport, results from this study found no differences between the treatment 
groups between 3 h and 6 h.   
When this study was designed, the horses that were assigned to each treatment 
were chosen by blocking for supplement treatment and temperament.  This caused 
horses that were not being housed together to be transported together in a loose group.  
When the horses were loaded into the trailer, the loose group spent several minutes 
biting, kicking and vocalizing to establishment of a dominance structure.  It is unknown 
if the group horses continued to display aggressive behavior during the time they were 
being transported.  The effect that social dominance had on glucocorticoid and DHEA 
concentrations within the loose group of horses is unknown. 
Horses that are transported in high density versus low density groups are more 
likely to fall or sustain injuries during transport (Collins et al., 2000).  In this study, the 
horses were carefully monitored during and after the transport period for falls or injuries 
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sustained during transport.  A brief visual inspection of the horses in the trailer was 
performed every hour during transport.  There was only one fall and 3 minor injuries that 
occurred over the course of the study.  All of those animals were in the group 
compartment at the time of the fall or injury, but all occurred on different days of 
transport.  In the case of the animal that fell, a visual inspection was made by the driver 
after 5 h of transport and all horses were upright in the trailer.  After 6 h of transport, an 
individual in the group compartment was noticed to be on the floor of the trailer in an 
upright recumbent position with its head up and alert, and legs curled under the body.  
The other horses in the group were removed, but the horse did not attempt to climb to its 
feet.  A researcher tugged the halter of the animal to encourage it to rise, but again, the 
horse showed no attempt.  Only after a second researcher began pushing the horse in the 
hind quarters at the same time the first researcher tugged at the halter, did the horse rise 
to its feet.  The horse appeared to exhibit what Overmier and Seligman defined as 
Learned Helplessness; where an animal that is presented with an adverse stimulus with 
no ability to stop it, will cease its attempts to avoid the stimulus (Overmier and 
Seligman, 1967).  The animal’s apathy toward standing when given space and 
opportunity, strongly indicated to this researcher that it stopped attempting to escape the 
fallen position prior to our presence.  Scrapes on the back and legs of the horse suggest 
that the animal had been stepped on by other animals in the group during the time that it 
was down, however, it sustained no major injuries and unloaded without hesitation or 
haste.  The 6 h transport blood sample was taken immediately after the horse was 
brought to its feet, and glucocorticoid and DHEA concentrations were closely examined 
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for this individual animal for any variation that may be due to the fall.  All hormone 
concentrations decreased from the previous sample at a rate consistent with other 
animals being transported at that time.  No indication that the fall caused significant 
changes in the horse’s hormone concentrations was noted, so data collected from the 
fallen horse was analyzed in the statistical model. 
 While glucocorticoids and DHEA concentrations were measured up to 4 hours 
post-transport and returned to pre-transport concentrations quickly, researchers 
monitoring the horses feed consumption indicated a possibility of residual effects of the 
transport in the form of reduced feed intake (Table 11).  A tendency for reduced intake 
was noted in Trial 1 were the average amount of hay refused during the 5 d period after 
transport was 1.7 times higher than the 5 d period prior to transport.  Differences in hay 
refusal amounts in Trials 2 and 3 were equal and negligible, possibly indicating an 
acclimation to transport after the first trial. 
 
Table 11. Average amounts of hay refused in time relative to transport for each trial. 
Time Period Hay Refused (kg) 
Trial 1 
     5 days pre-transport 0.191 
     5 days post-transport 0.325 
Trial 2 
     5 days pre-transport 0.257 
     5 days post-transport 0.299 
Trial 3 
     5 days pre-transport 0.48 
     5 days post-transport 0.413 
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It should be noted that the horses exercise programs were not consistent prior to 
transport in Trial 3.  All horses were being exercised, however, half of them were being 
lounged for 15 min per day, then handled and groomed for an additional 45 min per day, 
5 days per week, while the other half were lounged for 15 min per day, 3 days per week 
and turned out in groups of 2 for 45 min per day, 2 days per week.  After 15 days, the 
exercise assignments were reversed, such that every horse received equal exercise 
treatments over the inter-trial period.  This difference in exercise programs at the time of 
the transport trial could have an effect on glucocorticoid and DHEA concentrations 
found in samples taken during Trial 3. 
Differing exercise programs or individual stall housing may have contributed to 
an anomaly observed in the overall DHEA pattern in Trial 3.  Concentrations of DHEA 
did not fluctuate significantly during Trials 1 and 2, however, in Trial 3, pre-transport 
concentrations of DHEA were significantly higher than the previous 2 trials, then DHEA 
decreased significantly during transport.  While we observed a pattern of increased 
concentrations of cortisol and corticosterone during transport in all three trials, a 
decrease in DHEA during transport was not observed in Trials 1 and 2.  Because of 
multiple changes to the horses’ environment and routine, and a lack of replication of the 
follow-up experiment, it is unclear at this time what may have caused this spike pre-
transport and subsequent reduction in transport DHEA concentrations. 
 When comparing hormone concentrations between the first two trials and Trial 3, 
the blood samples collected during Trial 3 were not passed through the leukocyte 
filtration system prior to centrifugation, as happened in Trials 1 and 2.  Technical 
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representatives at Ambion, the manufacturer of the filtration system, noted that there 
should be no effect on the hormone concentrations within the plasma as a result of the 
filtration process.  The pore size of the filter is quite large in an effort to only capture 
white blood cells.  We did not, however, compare any samples by filtering a portion of 
the sample and testing both for accuracy.  Although it is reasonable to assume no effect, 
a comparison between filtered and non-filtered blood could be useful. 
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CONCLUSIONS 
 
Comparisons of plasma hormone concentrations between treatment groups in 
Trials 1 and 2 indicated that being transported in an individual stall versus a loose group 
did not have a significant effect on the amount of glucocorticoids and DHEA that are 
expressed in response to stress experienced during transport.  Hormone data from the 
follow-up experiment further supports the conclusion that there are no notable 
differences between concentrations of horses individually stalled during transport versus 
those transported in a loose group. 
The concentrations of cortisol and corticosterone observed for each animal 
during each of the three trials in this study clearly indicated that transport caused a 
significant rise in glucocorticoids, which subsequently returned to pre-transport 
concentrations within 2 hours of unloading.  This suggests that transport is a stressor for 
naïve horses, and that resistance of the stressor through glucocorticoid expression 
subsides quickly after the termination of the stressor. 
Horses fed different dietary supplements showed no significant differences in 
hormone concentrations in the absence of a stressor.  However, during the transport 
period in the first two trials, horses that were fed a sulfated form of supplement exhibited 
significantly higher concentrations of cortisol.  In addition, horses fed the sulfated form 
of supplement expressed significantly higher concentrations of DHEA in the follow-up 
experiment than horses that were fed a proteinated form of supplement.  This suggests 
49 
that horses fed a sulfated form of the mineral supplement may increase the hormone 
response to a stressor. 
The comparison of pre-transport cortisol and DHEA concentrations from the first 
two trials to Trial 3 suggest that maintaining the horses in individual stalls versus group 
paddocks resulted in increased basal concentrations of each of these hormones, and may 
suggest that additional underlying stress was experienced by the horses. 
Preliminary data obtained from the amplification of RNA samples suggest that 
some primers for inflammation related genes in humans may be useful in the detection 
of stress related physiological reactions in horses.  Further investigation is needed to 
determine if analysis of inflammatory-related gene expression by real-time PCR may 
provide a reliable index of stress in horses and other species. 
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APPENDIX 
 
Table 12. PCR evaluation of gene expression using primers for target inflammation 
genes in humans. 
Result Gene ID Gene Description 
- ABCF1 ATP-binding cassette, sub-family F (GCN20), member 1 
** BCL6 B-cell CLL/lymphoma 6 (zinc finger protein 51) 
- C3 Complement component 3 
- C4A Complement component 4A (Rodgers blood group) 
- C5 Complement component 5 
- CCL1 Chemokine (C-C motif) ligand 1 
- CCL11 Chemokine (C-C motif) ligand 11 
- CCL13 Chemokine (C-C motif) ligand 13 
- CCL15 Chemokine (C-C motif) ligand 15 
- CCL16 Chemokine (C-C motif) ligand 16 
- CCL17 Chemokine (C-C motif) ligand 17 
- CCL18 Chemokine (C-C motif) ligand 18 
- CCL19 Chemokine (C-C motif) ligand 19 
- CCL2 Chemokine (C-C motif) ligand 2 
- CCL20 Chemokine (C-C motif) ligand 20 
- CCL21 Chemokine (C-C motif) ligand 21 
- CCL23 Chemokine (C-C motif) ligand 23 
** CCL24 Chemokine (C-C motif) ligand 24 
- CCL25 Chemokine (C-C motif) ligand 25 
- CCL26 Chemokine (C-C motif) ligand 26 
- CCL3 Chemokine (C-C motif) ligand 3 
- CCL4 Chemokine (C-C motif) ligand 4 
- CCL5 Chemokine (C-C motif) ligand 5 
- CCL7 Chemokine (C-C motif) ligand 7 
- CCL8 Chemokine (C-C motif) ligand 8 
- CCR1 Chemokine (C-C motif) receptor 1 
- CCR2 Chemokine (C-C motif) receptor 2 
- CCR3 Chemokine (C-C motif) receptor 3 
** CCR4 Chemokine (C-C motif) receptor 4 
- CCR5 Chemokine (C-C motif) receptor 5 
- CCR6 Chemokine (C-C motif) receptor 6 
** CCR7 Chemokine (C-C motif) receptor 7 
- CCR8 Chemokine (C-C motif) receptor 8 
* CCR9 Chemokine (C-C motif) receptor 9 
** CEBPB CCAAT/enhancer binding protein (C/EBP), beta 
  *  Denotes genes that exhibited amplification with no expression differences between samples 
**  Denotes genes that exhibited amplification and showed differences in expression between samples 
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Table 12. Continued 
 
Result Gene ID Gene Description 
- CRP C-reactive protein, pentraxin-related 
** CX3CR1 Chemokine (C-X3-C motif) receptor 1 
- CXCL1 Chemokine (C-X-C motif) ligand 1  
- CXCL10 Chemokine (C-X-C motif) ligand 10 
- CXCL11 Chemokine (C-X-C motif) ligand 11 
** CXCL12 Chemokine (C-X-C motif) ligand 12  
- CXCL13 Chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) 
- CXCL14 Chemokine (C-X-C motif) ligand 14 
- CXCL2 Chemokine (C-X-C motif) ligand 2 
- CXCL3 Chemokine (C-X-C motif) ligand 3 
- CXCL5 Chemokine (C-X-C motif) ligand 5 
- CXCL6 Chemokine (C-X-C motif) ligand 6  
- CXCL9 Chemokine (C-X-C motif) ligand 9 
- ICEBERG ICEBERG caspase-1 inhibitor 
- IFNA2 Interferon, alpha 2 
- IL10 Interleukin 10 
- IL10RA Interleukin 10 receptor, alpha 
- IL10RB Interleukin 10 receptor, beta 
- IL13 Interleukin 13 
- IL13RA1 Interleukin 13 receptor, alpha 1 
- IL17C Interleukin 17C 
- IL1A Interleukin 1, alpha 
- IL1B Interleukin 1, beta 
- IL1F10 Interleukin 1 family, member 10 (theta) 
** IL1F5 Interleukin 1 family, member 5 (delta) 
- IL1F6 Interleukin 1 family, member 6 (epsilon) 
- IL1F7 Interleukin 1 family, member 7 (zeta) 
- IL1F8 Interleukin 1 family, member 8 (eta) 
- IL1F9 Interleukin 1 family, member 9 
- IL1R1 Interleukin 1 receptor, type I 
- IL1RN Interleukin 1 receptor antagonist 
- IL22 Interleukin 22 
- IL5 Interleukin 5 (colony-stimulating factor, eosinophil) 
- IL5RA Interleukin 5 receptor, alpha 
- IL8 Interleukin 8 
- IL8RA Interleukin 8 receptor, alpha 
- IL8RB Interleukin 8 receptor, beta 
- IL9 Interleukin 9 
**  Denotes genes that exhibited amplification and showed differences in expression between samples
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Table 12. Continued 
 
Result Gene ID Gene Description 
- IL9R Interleukin 9 receptor 
- LTA Lymphotoxin alpha (TNF superfamily, member 1) 
- LTB Lymphotoxin beta (TNF superfamily, member 3) 
- LTB4R Leukotriene B4 receptor 
** MIF Macrophage migration inhibitory factor (glycosylation-inhibiting factor) 
- SCYE1 Small inducible cytokine subfamily E, member 1 (endothelial 
monocyte-activating)
- SPP1 Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) 
** TNF Tumor necrosis factor (TNF superfamily, member 2) 
** CD40LG CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome) 
- TOLLIP Toll interacting protein 
** XCR1 Chemokine (C motif) receptor 1 
- B2M Beta-2-microglobulin 
** HPRT1 Hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome) 
- RPL13A Ribosomal protein L13a 
- GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
- ACTB Actin, beta 
** HGDC Human Genomic DNA Contamination 
** RTC Reverse Transcription Control 
** RTC Reverse Transcription Control 
** RTC Reverse Transcription Control 
** PPC Positive PCR Control 
** PPC Positive PCR Control 
** PPC Positive PCR Control 
**  Denotes genes that exhibited amplification and showed differences in expression between samples 
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Table 13. Gene expression as quantified by threshold cycle values for each amplified 
gene for a low cortisol responding animal (72) and a high cortisol responding animal 
(705).  Refer to Table 12 for descriptions of each gene. 
Gene ID 
Sample Identification 
72 705 
Pre-transport 4 h Pre-transport 4 h 
BCL6 20.73 19.85 21.26 19.27 
CCL24 27.53 26.52 29.33 32.91 
CCR4 27.8 29.77 29.65 27.44 
CCR7 27.06 28.67 27.38 27.94 
CCR9 27.14 27.54 27.36 27.77 
CEBPB 21.07 20.74 21.64 18.79 
CX3CR1 30.39 30.42 30.53 28.18 
CXCl12 31.31 33.06 33.5 31.72 
IL1F5 31.01 31.66 35.56 32.13 
MIF 32.07 32 32.07 30.65 
TNF 30.18 30.49 29.69 28.27 
CD40LG 35.09 35.66 33.81 33 
XCR1 28.21 28.28 29.5 25.66 
HPRT1 30.18 30.32 29.64 29.01 
64 
 
Table 14. Cortisol concentrations (ng/ml) of stalled horses in relation to time relative to 
start of transport in Trials 1 and 2. 
Animal 
ID 
Pre-transport Transport Post-transport 
 2 hrs 4 hrs 6hrs 2 hrs 4 hrs 
53 0.77 8.76 9.19 10.65 0.86 0.71 
57 1.31 9.85 10.58 9.72 3.63 3.67 
58 1.24 17.27 11.83 9.87 1.58 1.25 
63 0.75 7.23 12.05 10.30 1.03 0.66 
66 0.66 11.76 17.56 9.01 4.67 1.91 
72 2.20 9.19 13.82 10.18 5.25 7.83 
76 1.15 6.76 7.56 9.21 0.90 0.80 
205 2.08 17.41 8.71 7.88 2.63 2.65 
209 0.98 9.66 7.93 5.72 5.14 3.76 
310 1.40 31.59 35.98 36.74 5.46 1.44 
612 16.30 43.25 38.49 29.92 11.36 11.39 
614 1.31 16.46 17.90 10.58 2.03 3.89 
615 1.10 9.34 9.45 6.06 0.65 0.70 
618 0.60 15.60 15.60 11.76 0.86 0.76 
705 11.80 62.65 83.95 69.17 27.67 19.76 
710 0.72 11.45 9.32 6.72 0.85 0.76 
711 0.56 12.42 7.79 8.97 0.56 0.65 
720 2.31 39.01 41.23 34.29 5.35 4.10 
723 3.95 26.91 27.53 17.98 3.91 7.65 
726 3.68 19.61 18.50 16.32 1.91 2.98 
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Table 15. Cortisol concentrations (ng/ml) of group horses in relation to time relative to 
start of transport in Trials 1 and 2. 
Animal 
ID 
Pre-transport Transport Post-transport 
 2 hrs 4 hrs 6hrs 2 hrs 4 hrs 
53 2.49 11.50 16.04 12.61 1.54 2.57 
57 2.78 10.07 13.75 12.16 5.23 5.17 
58 1.73 18.28 18.11 16.86 2.20 1.06 
63 0.48 10.86 18.25 14.46 0.50 0.67 
66 2.66 19.82 13.29 11.27 4.12 4.36 
72 0.96 7.08 10.08 8.69 2.60 2.59 
76 0.90 4.66 7.42 3.65 0.89 0.78 
205 3.21 22.92 19.48 13.15 5.82 5.44 
209 0.32 2.64 6.77 4.33 1.12 0.55 
310 1.08 12.53 22.26 14.14 1.28 1.34 
612 6.97 13.20 18.99 11.88 5.47 3.91 
614 0.84 12.88 15.53 8.49 0.66 1.83 
615 0.45 8.13 6.43 5.27 0.46 0.42 
618 0.61 21.91 13.44 13.30 0.89 0.53 
705 15.87 69.31 77.45 60.78 35.82 3.61 
710 0.83 11.48 15.19 16.62 0.90 1.03 
711 1.04 5.47 2.75 2.12 0.76 0.67 
720 3.23 25.33 30.35 25.82 4.30 3.37 
723 8.92 29.58 30.05 27.52 8.76 7.51 
726 0.94 22.05 20.69 17.00 2.04 1.59 
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Table 16. Corticosterone concentrations (ng/ml) of stalled horses in relation to time 
relative to start of transport in Trials 1 and 2. 
Animal 
ID 
Pre-transport Transport Post-transport 
 2 hrs 4 hrs 6hrs 2 hrs 4 hrs 
53 1.12 5.51 6.82 8.30 2.97 0.42 
57 0.53 5.09 6.69 7.54 1.77 0.68 
58 2.23 7.29 6.40 5.54 2.88 0.55 
63 0.27 5.26 8.24 4.47 2.92 0.90 
66 1.66 8.56 10.46 7.02 2.85 1.50 
72 0.40 5.24 3.99 3.12 0.26 0.44 
76 7.69 19.80 19.80 21.42 5.20 2.40 
205 19.34 35.02 14.32 22.64 6.82 4.37 
209 1.78 13.48 10.98 8.04 2.04 4.96 
310 6.36 28.76 27.78 23.17 14.83 18.37 
612 24.01 36.67 33.83 29.02 16.68 7.60 
614 6.27 48.53 25.19 29.02 8.87 4.67 
615 14.94 29.02 13.43 10.92 3.74 3.64 
618 1.28 6.29 5.33 4.36 2.28 1.16 
705 2.66 12.23 7.75 7.96 1.63 2.19 
710 1.37 9.83 7.56 5.99 2.87 1.88 
711 6.06 45.58 48.23 38.25 6.32 4.63 
720 2.03 12.35 8.39 9.04 1.70 2.03 
723 2.13 10.94 7.57 7.77 1.48 1.41 
726 3.61 12.81 9.36 9.76 2.55 2.05 
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Table 17. Corticosterone concentrations (ng/ml) of group horses in relation to time 
relative to start of transport in Trials 1 and 2. 
Animal 
ID 
Pre-transport Transport Post-transport 
 2 hrs 4 hrs 6hrs 2 hrs 4 hrs 
53 1.05 5.99 6.16 4.42 0.82 3.03 
57 0.89 10.80 6.51 6.69 2.91 3.59 
58 1.34 7.98 8.03 5.68 0.95 1.83 
63 1.56 8.52 8.00 7.53 0.37 0.70 
66 1.23 6.38 4.18 3.03 2.02 1.12 
72 0.60 3.96 3.54 0.60 0.27 1.11 
76 0.72 7.24 13.58 8.80 3.45 3.04 
205 0.40 4.44 9.49 6.08 1.07 0.50 
209 3.16 9.35 10.30 5.02 2.19 1.62 
310 7.75 29.63 33.88 23.90 8.84 6.92 
612 9.07 11.33 14.88 14.18 3.26 3.44 
614 8.24 43.76 32.51 17.08 3.87 6.68 
615 6.58 16.13 14.50 11.19 4.43 6.74 
618 0.30 5.56 3.38 3.48 2.29 1.41 
705 4.48 7.32 7.18 9.15 1.78 0.43 
710 1.83 7.86 9.63 11.82 2.41 1.37 
711 6.18 34.63 48.07 38.69 15.48 1.83 
720 1.82 8.18 8.15 7.76 1.13 0.90 
723 2.81 10.93 9.34 10.93 3.61 1.34 
726 6.92 34.84 12.50 11.36 3.58 3.61 
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Table 18. Dehyrdoepiandrosterone (DHEA) concentrations (pg/ml) of stalled horses in 
relation to time relative to start of transport in Trials 1 and 2. 
Animal 
ID 
Pre-transport Transport Post-transport 
 2 hrs 4 hrs 6hrs 2 hrs 4 hrs 
53 813 12 1631 1567 828 844 
57 102 173 184 105 67 188 
58 102 85 34 108 102 127 
63 63 1938 2365 113 136 66 
66 895 1570 799 534 1981 1595 
72 636 581 619 465 526 652 
76 146 137 303 278 95 80 
205 712 798 412 928 477 532 
209 881 1834 1809 1716 184 1015 
310 390 344 355 511 283 173 
612 145 240 284 1774 185 328 
614 133 231 289 175 103 219 
615 196 471 335 103 321 272 
618 102 158 74 197 29 27 
705 898 416 469 361 200 343 
710 460 802 89 416 528 498 
711 859 861 281 593 962 866 
720 262 423 392 217 473 549 
723 1557 1736 954 859 1474 2786 
726 643 648 1479 551 472 633 
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Table 19. Dehyrdoepiandrosterone (DHEA) concentrations (pg/ml) of group horses in 
relation to time relative to start of transport in Trials 1 and 2. 
Animal 
ID 
Pre-transport Transport Post-transport 
 2 hrs 4 hrs 6hrs 2 hrs 4 hrs 
53 54 94 52 105 109 157 
57 72 1716 1615 1626 56 144 
58 345 120 581 76 267 270 
63 168 169 218 337 178 154 
66 218 158 2365 2038 111 114 
72 274 309 501 295 256 320 
76 166 57 54 93 946 573 
205 1207 476 714 456 937 1268 
209 204 142 163 3770 622 555 
310 280 370 259 221 45 270 
612 249 134 164 181 166 278 
614 55 412 276 425 194 129 
615 249 118 124 134 293 239 
618 148 43 87 872 842 12 
705 976 609 404 648 421 151 
710 189 1994 1885 1938 90 149 
711 1164 2291 748 811 1105 1478 
720 980 352 381 565 62 70 
723 385 299 221 252 369 360 
726 104 469 489 222 130 90 
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Table 20. Cortisol concentrations (ng/ml) of stalled horses in relation to time relative to 
start of transport in Trial 3. 
Animal 
ID 
Pre-transport Transport Post-transport 
 2 hrs 4 hrs 6hrs 2 hrs 4 hrs 
53 10.64 20.35 29.11 24.57 14.11 12.06 
63 2.23 18.11 17.85 9.49 1.73 4.73 
66 10.32 19.19 13.69 22.14 8.57 9.31 
72 8.16 21.85 28.93 14.39 7.59 8.59 
310 6.78 30.72 27.30 32.41 7.57 6.61 
612 18.88 29.07 33.27 28.31 7.55 8.37 
614 5.35 24.17 24.11 17.15 2.52 2.79 
705 17.38 46.03 55.51 55.90 9.38 8.29 
720 10.46 24.70 32.36 27.64 4.16 5.95 
723 2.16 14.19 16.46 12.41 10.35 6.11 
 
 
 
 
 
 
 
Table 21. Cortisol concentrations (ng/ml) of group horses in relation to time relative to 
start of transport in Trial 3. 
Animal 
ID 
Pre-transport Transport Post-transport 
 2 hrs 4 hrs 6hrs 2 hrs 4 hrs 
57 5.77 18.80 24.00 16.57 6.12 8.90 
58 3.98 19.31 28.30 17.49 4.46 5.05 
76 4.28 24.03 24.78 22.08 2.95 1.94 
205 16.48 37.94 34.54 27.52 18.47 15.12 
209 7.25 27.47 20.96 19.33 4.41 4.32 
615 2.66 15.66 22.47 15.50 4.65 3.46 
618 4.32 26.48 23.57 15.00 5.51 3.39 
710 3.60 25.39 17.64 13.74 7.35 3.71 
711 9.41 15.30 19.15 15.50 3.71 5.96 
726 7.25 24.36 24.89 13.89 8.96 8.31 
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Table 22. Corticosterone concentrations (ng/ml) of stalled horses in relation to time 
relative to start of transport in Trial 3. 
Animal 
ID 
Pre-transport Transport Post-transport 
 2 hrs 4 hrs 6hrs 2 hrs 4 hrs 
53 3.50 4.77 4.20 3.57 1.23 1.18 
63 7.06 13.70 10.69 9.23 36.16 8.29 
66 2.59 8.24 8.11 11.27 8.19 10.57 
72 48.15 37.56 56.64 44.65 8.72 20.56 
310 8.32 26.36 34.30 42.12 3.92 47.47 
612 8.91 14.40 11.99 9.16 10.69 3.14 
614 13.21 28.38 15.62 18.45 7.30 4.55 
705 3.00 10.40 17.41 26.95 6.87 5.63 
720 3.34 10.77 13.98 11.87 4.40 4.05 
723 2.72 12.95 11.59 12.57 5.97 5.37 
 
 
 
 
 
 
 
 
Table 23. Corticosterone concentrations (ng/ml) of group horses in relation to time 
relative to start of transport in Trial 3. 
Animal 
ID 
Pre-transport Transport Post-transport 
 2 hrs 4 hrs 6hrs 2 hrs 4 hrs 
57 2.21 5.67 7.39 4.18 1.32 2.44 
58 2.68 5.84 5.10 5.33 3.39 1.52 
76 9.08 16.01 24.50 16.53 16.41 11.61 
205 7.95 13.01 13.53 11.17 8.21 11.44 
209 5.17 11.87 8.71 7.39 8.40 15.23 
615 9.95 15.57 18.49 11.85 8.02 9.85 
618 2.34 5.24 2.14 2.99 6.37 2.05 
710 1.50 9.33 9.17 5.67 1.94 2.69 
711 7.23 11.36 10.42 6.35 5.72 11.30 
726 1.09 3.87 3.80 0.91 0.94 2.83 
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Table 24. DHEA concentrations (pg/ml) of stalled horses in relation to time relative to 
start of transport in Trial 3. 
Animal 
ID 
Pre-transport Transport Post-transport 
 2 hrs 4 hrs 6hrs 2 hrs 4 hrs 
53 1781 415 1479 262 402 171 
63 1103 542 79 693 286 190 
66 4742 637 719 2199 1675 1590 
72 3461 1694 3780 1436 1234 782 
310 4123 558 971 1894 3063 2487 
612 1867 725 87 910 1193 899 
614 1525 1125 343 1205 441 446 
705 2471 725 1551 1205 682 586 
720 607 209 457 795 592 1081 
723 757 1334 782 1533 1118 1363 
 
 
 
 
 
 
 
 
 
Table 25. DHEA concentrations (pg/ml) of group horses in relation to time relative to 
start of transport in Trial 3. 
Animal 
ID 
Pre-transport Transport Post-transport 
 2 hrs 4 hrs 6hrs 2 hrs 4 hrs 
57 51 1444 308 662 210 446 
58 1634 239 407 932 393 50 
76 864 256 298 329 838 419 
205 1153 987 1035 910 2647 1671 
209 1815 419 1052 262 429 240 
615 351 178 130 217 536 580 
618 281 272 76 191 26 34 
710 1129 859 1655 1655 1172 450 
711 2089 1010 437 1524 1455 1995 
726 342 1169 1084 940 2675 2877 
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